Evidence map›Paper›PMID 32084297›Full record

ArticleNMR in biomedicine2021

Preprocessing, analysis and quantification in single-voxel magnetic resonance spectroscopy: experts' consensus recommendations.

Jamie Near, Ashley D Harris, Christoph Juchem, Roland Kreis, Małgorzata Marjańska, Gülin Öz, Johannes Slotboom, Martin Wilson, Charles Gasparovic

Abstract readConsensus Statement
In one paragraph

Article in NMR in biomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Assessment of TMagma (New York, N.Y.) · 2026
    Article
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jamie NearDouglas Mental Health University Institute and Department of Psychiatry, McGill University, Montreal, Canada.ORCID 0000-0003-3516-936X
Ashley D HarrisDepartment of Radiology, University of Calgary, Calgary, Canada.ORCID 0000-0003-4731-7075
Christoph JuchemDepartments of Biomedical Engineering and Radiology, Columbia University, New York, New York.ORCID 0000-0002-1505-201X
Roland KreisDepartments of Radiology and Biomedical Research, University Bern, Switzerland.ORCID 0000-0002-8618-6875
Małgorzata MarjańskaCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-4727-2447
Gülin ÖzCenter for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-5769-183X
Johannes SlotboomSupport Center for Advanced Neuroimaging (SCAN), Neuroradiology, University Hospital Inselspital, Bern, Switzerland.ORCID 0000-0001-5121-9852
Martin WilsonCentre for Human Brain Health and School of Psychology, University of Birmingham, Birmingham, UK.ORCID 0000-0002-2089-3956
Charles GasparovicThe Mind Research Network, Albuquerque, New, Mexico.ORCID 0000-0002-4433-7815

Funding

TRD4 - Ultrahigh Field Engineering and SafetyP41EB027061 · NIBIB · UNIVERSITY OF MINNESOTA · PI Gregory John Metzger, KAMIL UGURBIL · 2019 to 2026
$11.7M
NMR Imaging and SpectroscopyP41EB015894 · NIBIB · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2017
$8.4M
Institutional Center Cores for Advanced NeuroimagingP30NS076408 · NINDS · UNIVERSITY OF MINNESOTA · PI UGURBIL, KAMIL · 2012 to 2020
$4.2M
Partnership for Magnetic Resonance Spectroscopy Biomarker Development-SupplementR01NS080816 · NINDS · UNIVERSITY OF MINNESOTA · PI OZ, GULIN · 2015 to 2019
$3.2M
CIHR PJT-148751CIHR PJT-165869NIBIB NIH HHS P41 EB015894NIBIB NIH HHS P41 EB027061NINDS NIH HHS P30 NS076408NINDS NIH HHS R01 NS080816
6 · The paper itself

Abstract

Once an MRS dataset has been acquired, several important steps must be taken to obtain the desired metabolite concentration measures. First, the data must be preprocessed to prepare them for analysis. Next, the intensity of the metabolite signal(s) of interest must be estimated. Finally, the measured metabolite signal intensities must be converted into scaled concentration units employing a quantitative reference signal to allow meaningful interpretation. In this paper, we review these three main steps in the post-acquisition workflow of a single-voxel MRS experiment (preprocessing, analysis and quantification) and provide recommendations for best practices at each step.

Indexed as

ConsensusMagnetic Resonance SpectroscopyBrainHumansMacromolecular SubstancesSignal Processing, Computer-AssistedMacromolecular SubstancesanalysisMRSpreprocessingprocessingquantificationquantitationwater referencing

Identifiers

PMID32084297
PMCPMC7442593

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.